Trademark Overview
On Wednesday, January 14, 2026, a trademark application was filed for LAZVUE with the United States Patent and Trademark Office. The USPTO has given the LAZVUE trademark a serial number of 99593960. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, January 14, 2026. This trademark is owned by Beacon Therapeutics Limited. The LAZVUE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical treatment services; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, preparations for gene therapy and cell therapy, medical diseases and disorders and related treatments; Medical treatment services in the field of ocular disorders; Provision of medical information and services in the field of ocular disorders.
Medical apparatus and instruments; medical apparatus and instruments used in the treatment of ocular disorders; apparatus and instruments for the administration of pharmaceutical preparations; apparatus and instruments for the injection of pharmaceutical preparations; medical apparatus and instruments for use in gene therapy and cell therapy.
Pharmaceutical preparations and substances; preparations for gene therapy and cell therapy; Pharmaceutical preparations and substances for the treatment of ocular disorders; biotechnological preparations for the treatment of ocular disorders; preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders.
